| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS10060771 | HBV | ENSG00000064651.14 | protein_coding | SLC12A2 | No | No | 6558 | B7ZM24 P55011 Q53ZR1 |
| TVIS10060780 | HBV | ENSG00000064651.14 | protein_coding | SLC12A2 | No | No | 6558 | B7ZM24 P55011 Q53ZR1 |
| TVIS10060768 | HBV | ENSG00000064651.14 | protein_coding | SLC12A2 | No | No | 6558 | B7ZM24 P55011 Q53ZR1 |
| TVIS10060772 | HBV | ENSG00000064651.14 | protein_coding | SLC12A2 | No | No | 6558 | B7ZM24 P55011 Q53ZR1 |
| TVIS10060779 | HBV | ENSG00000064651.14 | protein_coding | SLC12A2 | No | No | 6558 | B7ZM24 P55011 Q53ZR1 |
| TVIS10060774 | HBV | ENSG00000064651.14 | protein_coding | SLC12A2 | No | No | 6558 | B7ZM24 P55011 Q53ZR1 |
| TVIS10060775 | HBV | ENSG00000064651.14 | protein_coding | SLC12A2 | No | No | 6558 | B7ZM24 P55011 Q53ZR1 |
| TVIS10060782 | HBV | ENSG00000064651.14 | protein_coding | SLC12A2 | No | No | 6558 | B7ZM24 P55011 Q53ZR1 |
| TVIS30013920 | HIV | ENSG00000064651.14 | protein_coding | SLC12A2 | No | No | 6558 | B7ZM24 P55011 Q53ZR1 |
| TVIS30010901 | HIV | ENSG00000064651.14 | protein_coding | SLC12A2 | No | No | 6558 | B7ZM24 P55011 Q53ZR1 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | SLC12A2 |
|---|---|
| DrugBank ID | DB00214 |
| Drug Name | Torasemide |
| Target ID | BE0000281 |
| UniProt ID | P55011 |
| Regulation Type | inhibitor |
| PubMed IDs | 11752352; 8732438; 1632943 |
| Citations | Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5.@@Baumann P: Pharmacology and pharmacokinetics of citalopram and other SSRIs. Int Clin Psychopharmacol. 1996 Mar;11 Suppl 1:5-11.@@Hyttel J, Bogeso KP, Perregaard J, Sanchez C: The pharmacological effect of citalopram residues in the (S)-(+)-enantiomer. J Neural Transm Gen Sect. 1992;88(2):157-60. |
| Groups | Approved |
| Direct Classification | Pyridinesulfonamides |
| SMILES | CC(C)NC(=O)NS(=O)(=O)C1=C(NC2=CC=CC(C)=C2)C=CN=C1 |
| Pathways | Torsemide Action Pathway |
| PharmGKB | PA451733 |
| ChEMBL | CHEMBL1148 |
